Associated Papers
The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers.
Yamada A et al.
Pharmacogenetics and Genomics, 2011
Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.
Sai K et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
[Pharmacogenomics for adverse drug reactions].
Saito Y et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine, 2010
UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients.
Onoue M et al.
International Journal of Clinical Oncology, 2009
UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicity.
Biason P et al.
Journal of Chemotherapy (florence, Italy), 2008
Select a paper to view details